Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion type Assertion NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_head.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion description "[Overall, the XRCC1 homozygous variant gln399gln genotype was related to a significantly reduced risk of both basal cell [BCC; odds ratio (OR) 0.7, 95% confidence interval 0.4-1.0] and squamous cell carcinoma (SCC; OR 0.6, 95% confidence interval 0.3-0.9).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_provenance.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion evidence source_evidence_literature NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_provenance.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion SIO_000772 11782372 NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_provenance.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion wasDerivedFrom befree-20140225 NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_provenance.
- NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_assertion wasGeneratedBy ECO_0000203 NP739533.RAO8Z2Fa-LOV5z3hwEr7b9c6xukWZeY3wzBMrOhPTjbjc130_provenance.